GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » Cash-to-Debt

Aptamer Group (LSE:APTA) Cash-to-Debt : 1.66 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Aptamer Group's cash to debt ratio for the quarter that ended in Dec. 2023 was 1.66.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Aptamer Group could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Aptamer Group's Cash-to-Debt or its related term are showing as below:

LSE:APTA' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.22   Med: 5.12   Max: 48.36
Current: 1.66

During the past 4 years, Aptamer Group's highest Cash to Debt Ratio was 48.36. The lowest was 0.22. And the median was 5.12.

LSE:APTA's Cash-to-Debt is ranked worse than
69.99% of 1523 companies
in the Biotechnology industry
Industry Median: 6.39 vs LSE:APTA: 1.66

Aptamer Group Cash-to-Debt Historical Data

The historical data trend for Aptamer Group's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Aptamer Group Cash-to-Debt Chart

Aptamer Group Annual Data
Trend Mar19 Mar20 Jun22 Jun23
Cash-to-Debt
10.24 1.82 5.12 0.22

Aptamer Group Semi-Annual Data
Mar19 Mar20 Dec21 Jun22 Dec22 Jun23 Dec23
Cash-to-Debt Get a 7-Day Free Trial 48.36 5.12 5.35 0.22 1.66

Competitive Comparison of Aptamer Group's Cash-to-Debt

For the Biotechnology subindustry, Aptamer Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptamer Group's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptamer Group's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Aptamer Group's Cash-to-Debt falls into.



Aptamer Group Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Aptamer Group's Cash to Debt Ratio for the fiscal year that ended in Jun. 2023 is calculated as:

Aptamer Group's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aptamer Group  (LSE:APTA) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Aptamer Group Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Aptamer Group's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptamer Group (LSE:APTA) Business Description

Traded in Other Exchanges
N/A
Address
Innovation Way, Windmill House, York, GBR, YO10 5BR
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group (LSE:APTA) Headlines

No Headlines